Yaping Xie

553 total citations
33 papers, 349 citations indexed

About

Yaping Xie is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Yaping Xie has authored 33 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Yaping Xie's work include COVID-19 Clinical Research Studies (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Parasites and Host Interactions (3 papers). Yaping Xie is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Parasites and Host Interactions (3 papers). Yaping Xie collaborates with scholars based in China, Australia and United Kingdom. Yaping Xie's co-authors include Changcheng Shi, Nengming Lin, Junbo Xia, Qingyu Li, Limin Wang, Renjie Xu, Jian Ye, Zhi‐Chun Gu, Shuying Wang and David Hume and has published in prestigious journals such as Blood, Endocrinology and Frontiers in Immunology.

In The Last Decade

Yaping Xie

28 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaping Xie China 10 171 78 64 58 50 33 349
Kazuhiko Ikeuchi Japan 10 142 0.8× 129 1.7× 62 1.0× 115 2.0× 25 0.5× 40 368
Akshay Khatri United States 10 206 1.2× 77 1.0× 19 0.3× 24 0.4× 44 0.9× 26 354
Paul Patapis Greece 12 171 1.0× 57 0.7× 77 1.2× 90 1.6× 14 0.3× 17 693
Sowmya Nanjappa United States 10 69 0.4× 76 1.0× 83 1.3× 33 0.6× 12 0.2× 62 306
Víctor Moreno‐Torres Spain 13 176 1.0× 157 2.0× 57 0.9× 36 0.6× 69 1.4× 59 420
J.L. Pellegrin France 12 208 1.2× 101 1.3× 77 1.2× 28 0.5× 12 0.2× 27 463
Sara Cajander Sweden 10 75 0.4× 172 2.2× 26 0.4× 41 0.7× 48 1.0× 26 363
Oleg Epelbaum United States 11 305 1.8× 239 3.1× 39 0.6× 34 0.6× 34 0.7× 70 540
Richa Dewan India 14 209 1.2× 198 2.5× 57 0.9× 69 1.2× 11 0.2× 47 598
Nátalli Zanete Pereira Brazil 13 170 1.0× 91 1.2× 50 0.8× 81 1.4× 64 1.3× 29 525

Countries citing papers authored by Yaping Xie

Since Specialization
Citations

This map shows the geographic impact of Yaping Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaping Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaping Xie more than expected).

Fields of papers citing papers by Yaping Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaping Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaping Xie. The network helps show where Yaping Xie may publish in the future.

Co-authorship network of co-authors of Yaping Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yaping Xie. A scholar is included among the top collaborators of Yaping Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaping Xie. Yaping Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Yaping, et al.. (2024). Multifaceted role of GCN2 in tumor adaptation and therapeutic targeting. Translational Oncology. 49. 102096–102096. 3 indexed citations
2.
Xie, Yaping, Huifen Zhao, Shu Lin, et al.. (2024). Suppression of certain intestinal microbiota metabolites may lead to gestational diabetes in mice fed a high-fat diet. Frontiers in Microbiology. 15. 1473441–1473441.
3.
Shi, Tingting, et al.. (2024). The assessment of dupilumab in children with moderate-to-severe asthma and comorbid type 2 inflammatory diseases. BMC Pulmonary Medicine. 24(1). 607–607.
4.
Chen, Can, Yun Li, Yiwei Li, et al.. (2024). SNCA is a potential therapeutic target for COVID-19 infection in diffuse large B-cell lymphoma patients. APOPTOSIS. 29(9-10). 1454–1465. 2 indexed citations
6.
Shi, Changcheng, Limin Wang, Jian Ye, et al.. (2021). Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infectious Diseases. 21(1). 663–663. 111 indexed citations
7.
Shi, Changcheng, Qiyuan Shan, Junbo Xia, et al.. (2021). Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta‐analysis. Mycoses. 65(2). 152–163. 28 indexed citations
8.
Shi, Changcheng, Junbo Xia, Jian Ye, et al.. (2021). Effect of renal function on the risk of thrombocytopaenia in patients receiving linezolid therapy: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 88(2). 464–475. 24 indexed citations
9.
10.
Li, Yiwei, et al.. (2020). Huanglian Jiedu Decoction for treatment of multiple myeloma. Medicine. 99(51). e22378–e22378. 3 indexed citations
11.
Xu, Xuehua, Bingtai Lu, Yaping Xie, et al.. (2020). A novel mutation in CYBB induced X-linked chronic granulomatous disease: A case report. Respiratory Medicine Case Reports. 31. 101213–101213. 1 indexed citations
12.
Pan, Qun, et al.. (2019). Effect of Cytotoxic T-Lymphocyte Antigen-4 on the Efficacy of the Fatty Acid-Binding Protein Vaccine Against Schistosoma japonicum. Frontiers in Immunology. 10. 1022–1022. 3 indexed citations
13.
Shi, Changcheng, Weizhong Jin, Yaping Xie, et al.. (2019). Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: An updated systematic review and meta-analysis. Journal of Global Antimicrobial Resistance. 21. 235–245. 22 indexed citations
14.
Xie, Yaping, et al.. (2019). Effects of regulatory T cells on glyceraldehyde-3-phosphate dehydrogenase vaccine efficacy against Schistosoma japonicum. Acta Tropica. 202. 105239–105239. 6 indexed citations
15.
Fan, Huifeng, Huang Li, Diyuan Yang, et al.. (2018). Pediatric hyperimmunoglobulin E syndrome. Medicine. 97(14). e0215–e0215. 21 indexed citations
17.
Xie, Yaping, Dan Yu, Jiahua Wu, & Lin Li. (2017). Protective effects of physiological testosterone on advanced glycation end product-induced injury in human endothelial cells. Molecular Medicine Reports. 15(3). 1165–1171. 8 indexed citations
18.
Lu, Gen, Yaping Xie, Li Huang, et al.. (2016). Study of Acute Exogenous Lipoid Pneumonia. The Indian Journal of Pediatrics. 83(8). 787–791. 8 indexed citations
19.
Xie, Yaping, et al.. (2015). Successful use of splenectomy in a patient with hepatitis C virus-related thrombocytopenia. The Journal of Infection in Developing Countries. 9(7). 785–787.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026